106 related articles for article (PubMed ID: 8930444)
1. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.
Björkander J; Fasth A; Widell A
Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study.
Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC
JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853
[TBL] [Abstract][Full Text] [Related]
3. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
[TBL] [Abstract][Full Text] [Related]
4. At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C.
Widell A; Zhang YY; Andersson-Gäre B; Hammarström L
Transfusion; 1997 Mar; 37(3):313-20. PubMed ID: 9122906
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.
Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H
Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus transmission by intravenous immunoglobulin.
Yap PL; McOmish F; Webster AD; Hammarstrom L; Smith CI; Bjorkander J; Ochs HD; Fischer SH; Quinti I; Simmonds P
J Hepatol; 1994 Sep; 21(3):455-60. PubMed ID: 7836718
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain.
Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P
Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia.
Quinti I; Pandolfi F; Paganelli R; Giovannetti A; Sacco G; Oliva A; Aiuti F
Clin Ther; 1996; 18 Suppl B():96-107. PubMed ID: 8930447
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
11. Gammagard and reported hepatitis C virus episodes.
Gomperts ED
Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438
[TBL] [Abstract][Full Text] [Related]
12. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
Jonas MM; Baron MJ; Bresee JS; Schneider LC
Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin and hepatitis C virus: an overview of transmission episodes with emphasis on manufacturing data.
Yap PL
Clin Ther; 1996; 18 Suppl B():43-58. PubMed ID: 8930441
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection: clinical aspects and treatment with interferon alfa.
Jonas MM
Clin Ther; 1996; 18 Suppl B():110-25. PubMed ID: 8930449
[TBL] [Abstract][Full Text] [Related]
16. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus screening and intravenous immunoglobulin safety in Japan.
Nishioka K
Clin Ther; 1996; 18 Suppl B():83-92. PubMed ID: 8930445
[TBL] [Abstract][Full Text] [Related]
18. The viral safety of intravenous immune globulin.
Yap PL
Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus RNA in patients with anti-HCV on hemodialysis. Relationship to transaminase levels.
Garcia-Valdecasas J; Bernal C; Cerezo S; Garcia F; Montiel N; Leyva A; Umana WO; Bosch JP
ASAIO J; 1994; 40(3):M450-3. PubMed ID: 8555556
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin.
Taliani G; Guerra E; Rosso R; Badolato MC; Luzi G; Sacco G; Lecce R; De Bac C; Aiuti F
Transfusion; 1995 Feb; 35(2):103-7. PubMed ID: 7825204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
